An important issue for chromatin remodeling complexes is how their bromodomains recognize particular acetylated lysine residues in histones. The Rsc4 subunit of the yeast remodeler RSC contains an essential tandem bromodomain (TBD) that binds acetylated K14 of histone H3 (H3K14ac). We report a series of crystal structures that reveal a compact TBD that binds H3K14ac in the second bromodomain and, remarkably, binds acetylated K25 of Rsc4 itself in the first bromodomain. Endogenous Rsc4 is acetylated only at K25, and Gcn5 is identified as necessary and sufficient for Rsc4 K25 acetylation in vivo and in vitro. Rsc4 K25 acetylation inhibits binding to H3K14ac, and mutation of Rsc4 K25 results in altered growth rates. These data suggest an autoregulatory mechanism in which Gcn5 performs both the activating (H3K14ac) and inhibitory (Rsc4 K25ac) modifications, perhaps to provide temporal regulation. Additional regulatory mechanisms are indicated as H3S10 phosphorylation inhibits Rsc4 binding to H3K14ac peptides.
INTRODUCTION
Chromatin serves a central role in regulating the access of transcription factors to chromosomal loci. The primary repeating unit of chromatin, the nucleosome, helps organize DNA topology by wrapping DNA, a property that can occlude binding sites for regulatory factors and thereby contribute to transcriptional silencing (Kornberg and Lorch, 1999) . However, the nucleosome is a dynamic participant in transcriptional activation, because nucleosome remodelers function to reposition nucleosomes to expose the underlying DNA. Furthermore, a large array of covalent modifications occur on the histone components and can serve as binding epitopes for protein domains specialized for their recognition. The principle of histone marking by covalent modification and recognition by specific domains has been termed ''the histone code' ' (Fischle et al., 2003; Strahl and Allis, 2000) . These binding domains reside on both chromatin regulators and transcriptional regulators. Thus, most factors are targeted to particular locations in the genome by one of two mechanisms: through interactions with site-specific DNA binding proteins or by using specialized domains to interact with modified histones. The most common posttranslational modification of histones is the acetylation of lysine residues by histone acetyltransferase (HAT) enzymes, which occurs primarily on the flexible N-terminal histone ''tails'' that emanate from the globular nucleosome core (Kouzarides, 2000) . One of the best-studied HAT enzymes is yeast Gcn5, which acetylates lysine 14 of histone H3 (H3K14ac), a modification correlated with transcriptional activation (Brownell et al., 1996; Howe et al., 2001; Lo et al., 2000; Syntichaki et al., 2000; Trievel et al., 1999) . Acetylated lysines are typically bound by $110 amino acid residue structures called bromodomains that also recognize several of the residues flanking the acetyl-lysine, thereby providing acetyl-lysine recognition within a sequence context (Hudson et al., 2000; Mujtaba et al., 2002; Owen et al., 2000) . There is considerable interest in determining which bromodomains bind particular histone acetyl-lysines and whether these interactions mediate targeting or some other aspect of regulation.
Complexes that rely on bromodomains for their full function include chromatin remodelers, which use the energy of ATP hydrolysis to move and/or eject nucleosomes to uncover the underlying DNA (Cairns, 2005) . Indeed, how remodelers are targeted and regulated is a central question in chromatin biology. Important initial work demonstrated that bromodomains present on the yeast remodeler SWI/ SNF are important for the retention of the remodeler on acetylated chromatin templates, consistent with a role for bromodomains in targeting (Hassan et al., 2002 (Hassan et al., , 2006 . The paralog of ySWI/SNF is the 15 subunit remodels the structure of chromatin (RSC) complex, which is both abundant and essential in S. cerevisiae (Cairns et al., 1996) and is involved in multiple chromosomal processes including transcriptional regulation, DNA repair, stress response, and chromosome cohesion and segregation (Angus-Hill et al., 2001; Baetz et al., 2004; Cairns et al., 1999; Chai et al., 2005; Chang et al., 2005; Yukawa et al., 1999) . Importantly, RSC subunits contain 8 of the 15 bromodomains in S. cerevisiae, indicating that histone acetylation likely plays a central role in recruiting RSC to chromatin and/or in regulating its remodeling activity. Consistent with this notion, acetylation of histones promotes nucleosome remodeling by RSC and the passage of RNA polymerase II through chromatin in vitro (Carey et al., 2006) .
The Rsc4 subunit of the RSC complex, which contributes to RSC-activated Pol II transcription in vivo (Kasten et al., 2004; Soutourina et al., 2006) , contains a pair of bromodomains, termed BD1 and BD2, that are essential for cell viability (Kasten et al., 2004) . BD1 and BD2 are adjacent in the primary protein sequence and together form the Rsc4 tandem bromodomain (TBD, residues 56-304). Our previous studies indicated that the Rsc4 TBD binds H3K14ac (Kasten et al., 2004) . For example, the Rsc4 TBD preferentially binds histone H3 N-terminal peptides acetylated at K14, but not at several other positions tested on both the H3 and the H4 tails. Furthermore, conditional rsc4 alleles are lethal in combination with gcn5D (Gcn5 acetylates H3K14) or with h3K14 replacements (at 33 C), but not in combination with mutation of other lysine residues in the H3 and H4 tails (Kasten et al., 2004) . However, it was unresolved which of the bromodomains (or both) bound H3K14ac, and the clear possibility remained of alternative ligands. Furthermore, it was not known whether other modifications occurring near H3K14ac, such as H3S10 phosphorylation, might affect binding.
To better understand Rsc4 recognition of chromatin, we performed biochemical and genetic studies that showed that only BD2 binds to H3K14ac peptides, and we visualized the acetyl lysine component of this interaction using X-ray crystallography. Serendipitously, crystal structure determination of protein prepared by in vitro acetylation with Gcn5 revealed that an acetylated lysine of Rsc4(K25ac) binds to its own BD1. This interaction was shown to be important in vivo, and the modifying enzyme was identified as Gcn5, the same acetyltransferase that modifies the H3K14 ligand of BD2. Importantly, peptidebinding data showed that binding of Rsc4 K25ac to BD1 impairs the ability of BD2 to bind an H3K14ac peptide, thereby indicating an autoregulation mechanism for recognition of a histone modification.
RESULTS AND DISCUSSION
Structure of the Rsc4 Tandem Bromodomain Several crystal structures of Rsc4 constructs were determined (Figure 1 ). The first, Rsc4(36-340), was determined by the SAD method using selenomethionine-substituted protein and refined to a free R value of 21.8% against native data to 1.8 Å resolution. This structure is ordered from residue 36 to residue 320 with no disordered internal loops. Structures of other constructs were subsequently determined by molecular replacement and refined to resolutions of 1.75-2.35 Å and R free values of 21.9%-24.8%. While the structures varied significantly in their last ordered residue (313-320), only minor differences were seen for residues 36-312, with root-mean-square deviations (rmsds) of 0.5-1.0 Å following least-squares overlap on 275 pairs of Ca atoms.
The Rsc4 TBD is a compact structure in which each of the individual bromodomains (BD1 and BD2) resembles bromodomains from other proteins (Mujtaba et al., 2002; Owen et al., 2000; Sun et al., 2007) . In keeping with standard nomenclature, we name the four bundle helices Z, A, B, and C, with a -1 or -2 suffix to indicate if it is from the first or second bromodomain ( Figure 1C ). The acetyl-lysine binding pockets are formed primarily by residues within the BC and ZA loops including the short helix Z 0 . Both BD1 and BD2 conserve two tyrosine residues within Z 0 and an asparagine residue within B that are characteristic of bromodomain binding sites. Overlap on Ca atoms with the bromodomain from Gcn5, which shares 19% and 33% sequence identity with Rsc4 BD1 and BD2, respectively, and whose crystal structure has been determined at 1.9 Å resolution (Owen et al., 2000) , gives rmsds of 1.8 Å (100 pairs of Ca atoms) for BD1 and 1.6 Å (106 pairs of Ca atoms) for BD2.
The Rsc4 TBD reveals important differences with the previously reported structure of the double bromodomain of TAF II 1 (formerly termed Taf II 250) , the largest subunit of the TBP-associated factors for RNA Pol II transcription. We note that TAF II 1 was only crystallized in the absence of ligand. Notably, the relative positions and orientations of the two bromodomains in Rsc4 are very different to those in TAF II 1 (see Figure S1 in the Supplemental Data available with this article online). Also, Rsc4 is substantially more compact, with extensive BD1-BD2 interactions (mainly through aC-1 and aB-2) that bury a total of 1621 Å 2 of solvent accessible surface area at the bromodomain interface ( Figure S2 ). In comparison, 1122 Å 2 are buried at the BD1-BD2 interface in the TAF II 1 structure. This supports the impression from genetic data that the Rsc4 TBD functions as a single structural unit (Kasten et al., 2004) . In contrast, the two bromodomains of TAF II 1 appear to be relatively independent. As a result of these differences, the two acetyl-lysine binding sites of Rsc4 face the same side of the structure in the same relative orientation and are separated by just 20 Å . Whereas BD1 conforms to the standard bromodomain architecture, BD2 includes an additional ''wing'' helix (W) inserted between Z-2 and A-2. Because it is adjacent to the presumed binding surface, we hypothesized that W might play an important functional role. We therefore designed a deletion variant that replaced residues 187-206 with a short Ser-Ser-Gly linker, termed rsc4D187-206. Although the rsc4D187-206 allele does not confer a strong phenotype in isolation, a temperature-sensitive (ts À )
Figure 1. Structures of Rsc4
(A) Domain organization of Rsc4 (top) and crystallized constructs (bottom). Rsc4 structure is the following: bromodomain 1 (cyan), bromodomain 2 (blue), wing insertion (orange), and the binding region for RSC and the RNA polymerases (green) (Kasten et al., 2004; Soutourina et al., 2006) . First and last ordered residues in the crystallized constructs are indicated with arrows. Acetylated lysine residues are indicated with a magenta dot (K14 of H3 and K25 of Rsc4).
(B) Orthogonal views of Rsc4(36-340) ribbon diagram. Secondary structures are labeled, and termini are indicated N and C. The asparagine and two tyrosine side chains from each bromodomain that are important for acetyl lysine binding are colored yellow. The wing insertion is colored orange. (C) Rsc4 amino acid sequence with secondary structures indicated above. Residues not ordered in the Rsc4(36-340) structure are indicated with a dashed line. The red squares indicate interface residues between BD1 (residues 36-162) and BD2 (residues 163-320). The magenta circle indicates the site of acetylation (K25).
phenotype was conferred in combination with gcn5D (data not shown), suggesting that the wing might assist BD2 in H3K14ac recognition.
H3K14ac Binds Preferentially to Rsc4 BD2
We took both in vivo and in vitro approaches to determine which of the two Rsc4 bromodomains binds H3K14ac. Our in vivo approach involved isolating mutations specifically impaired at individual bromodomains and testing them in combination with gcn5D and h3K14 mutations. First, we made mutations in BD1 or BD2 of two tyrosine residues that are highly conserved in all bromodomains ( Figure S3 ) and are important for recognizing the acetyl moiety in acetyl-lysine. Replacement of these tyrosines with alanine resulted in the rsc4 alleles rsc4 Y92A Y93A (BD1 mutant), rsc4 Y225A Y226A (BD2 mutant), and the combined rsc4 Y92A Y93A Y225A Y226A (BD1&2 mutant) alleles. Each encoded a stable derivative that was fully capable of assembly into the RSC complex (data not shown).
The isolated BD mutant alleles lack clear plate phenotypes, likely due to the fact that the normal interaction of bromodomains with their substrates involves an interaction with the acetyl moiety (which is compromised) and also the peptide sequence (which is retained). However, the combined BD1&2 mutations conferred lethality (even in WT GCN5 background, Figure 2A ). This demonstrates that the two bromodomains are partially redundant; compromising the acetyl-binding pocket of both bromodomains is needed to confer inviability. We note that redundancy can result from the two bromodomains binding to different ligands; compromising one bromodomain makes Rsc4 reliant on the alternative bromodomain and its ligand(s) to conduct an essential function.
In support of the two bromodomains binding different ligands, we found that rsc4 Y92A Y93A gcn5D combinations were lethal, whereas rsc4 Y225A Y226A gcn5D combinations grew well ( Figure 2A ). As above, lethality could result from compromising both BD1 and BD2; BD1 is compromised through mutation of the tyrosine residues and BD2 through the lack of the acetyl group on the H3K14 substrate in the gcn5D background. Consistent with this notion, synthetic lethality was also observed when the BD1 mutant was combined with the h3K14G mutant ( Figure 2A ). These data implicate BD2 in binding H3K14ac, because mutations in BD2 that prevent the recognition of the acetyl moiety (Y225A, Y226A) are not expected to be exacerbated by the absence of the acetyl group on the substrate (from gcn5D). In contrast, the synthetic lethality observed by combining a BD1 mutation with gcn5D implicates an important function for BD1 in binding a ligand(s) distinct from H3K14ac.
An NMR titration experiment indicated that the Rsc4-H3K14ac peptide dissociation constant is approximately 1-2 mM (data not shown). This low inherent binding is not unusual for bromodomains (Hudson et al., 2000; Shen et al., 2007; Sun et al., 2007) and presumably reflects the involvement of additional contacts with the nucleosome in the context of the intact RSC complex. It does, however, limit the choice of binding assay, and we therefore estimated relative binding affinities using biotinylated H3 tail peptides (residues 1-39) that were either acetylated at K14 or unmodified, and were immobilized on streptavidin beads. This analysis revealed that Rsc4(46-334) binds H3K14ac peptides in preference to unmodified peptides ( Figure 2B ). Consistent with the genetic experiments, the Y92F variant (intact BD2) binds H3K14ac peptides preferentially in the same manner as the wild-type (WT) sequence, whereas preferential binding is abolished with the equivalent mutation in BD2 (Y225F) ( Figure 2B ). Moreover, a Rsc4(157-321) BD2 derivative that lacked BD1 entirely still demonstrated a preferential interaction with H3K14ac peptides compared to unmodified peptides ( Figure 2C ). Not surprisingly, given the extensive interactions between BD1 and BD2, peptide binding to the isolated BD2 structure was weaker than to the TBD, and the isolated BD1 was insoluble (data not shown). The binding assay was further used to map the Rsc4 interaction to residues 6-21 of the H3K14ac peptide, with further truncation from the N terminus preventing binding to the intact Rsc4(36-321) (data not shown). Thus, these data indicate that Rsc4 BD2 preferentially binds the H3 tail acetylated at K14 with other interactions also contributing to binding affinity. We also examined whether or not modifications near H3K14 affect H3K14ac recognition. Previous work suggested that H3K9 acetylation does not affect Rsc4 binding (Kasten et al., 2004) . However, S10 phosphorylation has previously been linked to H3K14 acetylation (Lo et al., 2000) and had not been examined in our prior studies. We find that S10 phophorylation antagonizes selective binding of Rsc4(36-321) to H3K14ac peptides, raising the possibility that this modification may restrict RSC binding in vivo ( Figure 2D ).
Structure of Rsc4 BD2 Bound to H3K14ac
To visualize the H3-Rsc4 interaction, we determined the structure of a peptide complex by soaking Rsc4(36-340) crystals in high concentrations ($40 mM) of H3(6-18)K14ac (Table 1) . Density for the peptide backbone is not apparent in this 1.7 Å resolution structure but is clearly defined for an acetylated lysine side chain in the BD2 binding site in a conformation that overlaps closely with the structure of a Gcn5 bromodomain ligand complex (Figure 2E) . Unfortunately, density was not reliably interpretable beyond the side chain, and it was not possible to determine the path of the bound peptide backbone. Numerous data sets were obtained and structures determined at 1.7-2.3 Å resolution for Rsc4(36-340) cocrystallized or soaked with H3 peptide, but ligand density was always limited to the Kac side chain. The BD1 and BD2 pockets are open in the crystal lattice, although they are each within 6 Å of significant crystal contacts. Because in vitro binding appears normal in the 6-21 H3K14ac peptide but is abolished in a 10-21 peptide (data not shown), it seems likely that lattice contacts prevent secondary interactions that are important for full binding affinity and block the peptide from adopting the bound conformation outside of the primary binding pocket. Nevertheless, this structure supports the genetic and biochemical studies by showing that H3K14ac can bind Rsc4 BD2.
Rsc4 K25ac Binds BD1
In an effort to overcome the problem of low-affinity binding and to visualize a bound H3 peptide better, we took a chimera approach in which a very high local concentration of H3 peptide might be achieved by expressing the H3 tail as a fusion with the Rsc4 N terminus. The fusion included H3 residues 6-18, followed by eight residues containing a thrombin cleavage site, followed by Rsc4 residues 1-321 ( Figure 1A ). This construct contained the entire N-terminal sequence of Rsc4, whereas our initial crystal structures lacked the first 35 residues. The purified chimeric protein was acetylated at H3K14 using purified recombinant Gcn5, with progress of the reaction monitored by migration of the H3 peptide (following treatment and release with thrombin) using acid-urea gel electrophoresis. Acetylation was also monitored by western analysis, which revealed high levels of H3K14ac and very low levels of H3K9ac (data not shown). To more definitively identify the acetylated lysines, we subjected tryptic fragments to mass spectrometric analysis. This revealed nearly complete acetylation at H3K14 and, surprisingly, nearly complete acetylation at Rsc4 K25. As described below, the modification of K25 was unexpected but highly fortuitous. The acetylated chimeric H3-Rsc4 protein was crystallized and the structure determined. Counter to the design goal, H3 residues were not ordered, and the BD2 pocket appeared to be empty. This was disappointing, but given the lack of information about likely binding orientation, the failure was not surprising. Remarkably, however, Rsc4 K25ac was present in the BD1 pocket, and the surrounding residues were well ordered, starting at residue 19 ( Figure 3 ). An essentially identical arrangement was revealed in the subsequently determined crystal structure of Rsc4(1-340) bearing K25ac. This derivative bore its natural N terminus and lacked the H3 peptide, and quantitative acetylation at K25 (by Gcn5) was verified by mass spectrometry (data not shown). This binding could be recapitulated in trans, as a peptide containing Rsc4 residues 18-34 acetylated at K25 interacted with the TBD protein in vitro, though with low affinity ( Figure S4 ). Figure 4A ). To identify the acetyltransferase that modifies Rsc4 in vivo, we expressed in yeast a Rsc4(1-340) construct that also included a nuclear targeting sequence and a 10 3 HIS tag. We then purified this protein with nickel chelating chromatography and examined its acetylation state. Western analysis revealed clear acetylation in the WT strain and in a wide variety of strains lacking specific acetyltransferases. However, Rsc4 K25 acetylation was abolished in a strain lacking Gcn5 ( Figure 4B ). As a definitive test for the presence of Gcn5-dependent Rsc4 K25ac in the RSC complex in vivo, we made a Rsc4 derivative with a single amino acid replacement (K25A) as the sole source of Rsc4. This derivative or the WT Rsc4 was expressed in WT cells and purified as a component of the RSC complex using a TAP tag on the Rsc2 subunit ( Figure 4C , lanes 1 and 2). Importantly, substitution of K25 abolished the acetylation of Rsc4 ( Figure 4C , lanes 1 and 2). Furthermore, acetylation of WT Rsc4 present in the RSC complex was abolished when Rsc4 was isolated from a strain lacking Gcn5 ( Figure 4C , lanes 3 and 4). The functional importance of K25 is supported by sequence alignment, which reveals that this lysine is highly conserved within yeast Rsc4 orthologs ( Figure 4D ). Moreover, G24 and P27 are also highly conserved, and the GKXP sequence matches the Gcn5 recognition motif determined from structural analysis of a Gcn5 HAT-histone H3 complex .
Rsc4 K25 Is Important for Fitness and Gene Expression
To examine the in vivo consequences of Rsc4 K25 acetylation, we made a K25A mutation and assessed phenotypes. The Rsc4 K25A mutation in isolation (and also K25R and K25Q) conferred only weak plate phenotypes, such as slightly slower growth on minimal medium under moderate heat stress ( Figure S4 ). However, combining K25A with a conditional rsc4 allele (rsc4-2, which has a point mutation in each bromodomain [Kasten et al., 2004] ) greatly enhanced temperature sensitivity (Figure S4 ). This supports the proposal that acetylation of Rsc4 K25 contributes to RSC function in vivo. Subtle phenotypic effects can confer a fitness advantage that might be more clearly revealed in a growth competition assay. We therefore measured the fitness of the rsc4 K25A mutant in direct competition with an isogenic WT strain and quantified gene fitness by the selection coefficient (s), which was obtained by comparing growth of the rsc4 K25A mutant and the WT RSC4 strain in coculture (Table 2) . In this analysis, positive values of s indicate a selective disadvantage for the K25A mutant, while negative values of s indicate a greater selective advantage compared to WT. Surprisingly, under rich growth conditions (YPD, 30 C) the K25A mutant has a greater selective advantage (s = À0.018), indicating a 1.8% increase in the mutant K25A allele per generation in the coculture population under these conditions. In contrast, growth in minimal medium conditions (SD, 30 C) provides a selective advantage for the WT (s = 0.021), and this advantage is further increased (s = 0.087) when grown in minimal medium at elevated temperature (SD, 37 C). The loss of fitness for the K25A mutation when grown in minimal media conditions is highly significant (p < 0.01) and corresponds to an approximate 2.1% (30 C) or 8.7% (37 C) decrease in the K25A allele every generation.
We also examined the rsc4 K25A mutant for changes in gene expression by performing transcriptional profiling from cells grown in minimal medium at slightly elevated temperature (33 C). In the K25A mutant, 80 genes were upregulated 2-fold or greater, and 61 genes were downregulated 2-fold or greater (Tables S1 and S2 ). Among the upregulated class, we did not observe a greater affect on genes of a particular inherent transcriptional frequency. Common classes of upregulated genes include those involved in cell wall integrity, those involved in the response to cell stress, and those encoding proteins that reside in the cell membrane. Misregulation of genes involved in cell wall integrity has been observed with other rsc mutants, including conditional rsc4 alleles (Angus-Hill et al., 2001; Kasten et al., 2004) . Taken together, our genetic Figure 5A ). The importance of K25ac binding to BD1 for this inhibition was tested more precisely by using Rsc4(1-321) Y92A protein, which is crippled for binding to BD1. Importantly, binding to H3K14ac peptides is largely restored in the Y92A (A) Rsc4 K25 acetylation inhibits H3K14ac binding. Binding of purified nonacetylated and acetylated TBD to biotinylated histone H3 tail peptides conjugated to streptavidin beads was examined by western analysis. Rsc4(36-321) TBD was expressed from p1617 and Rsc4(1-321) TBD was expressed from p1616. Rsc4(1-321) TBD was acetylated by Gcn5 where indicated, and acetylation at K25 was confirmed by mass spectrometry analysis (data not shown). Binding and wash buffers contained 100 mM NaCl. (B) Western blot analysis of purified WT and mutant acetylated Rsc4(1-321) TBD bound to H3 peptides. Bead bindings and washes were conducted at 150 mM NaCl. Rsc4 K25ac(1-321) TBD was expressed from p1617 and Rsc4 K25Ac(1-321) Y92A TBD was expressed from p2296. Proteins were acetylated by Gcn5, and acetylation was confirmed by mass spectrometry analysis (data not shown).
(C) Model for Rsc4 autoregulation. Gcn5 acetylation of H3K14 facilitates Rsc4 interaction with H3K14ac and also the subsequent release of Rsc4 from chromatin by acetylating Rsc4 K25, which binds in BD1 and antagonizes Rsc4 binding to H3K14ac.
derivative, thereby indicating that binding of K25ac to BD1 is coupled with inhibition of H3K14ac binding to BD2 (Figure 5B) . The mechanism for this inhibition is not immediately obvious, because BD1 and BD2 are separated by 20 Å . Our preferred model is that N-terminal residues that become ordered upon binding of K25ac to BD1 overlap the site of H3 residues that bind cooperatively with the K14ac -BD2 interaction, although an allosteric propagation of a subtle conformational change is also possible.
Models for Biological Mechanism
Our structural, biochemical, and genetic data have established that H3K14ac binds Rsc4 BD2 and that additional interactions with flanking residues in the H3 tail (not resolved in the structure) also contribute to binding affinity. The interaction is inherently weak, but it is specific and biologically important, and binding in the biological context is presumably enhanced by cooperative effects involving the additional DNA-and nucleosome-interacting domains, such as the SWIRM, SANT, and additional bromodomains of RSC subunits (Boyer et al., 2002; Da et al., 2006; Yu et al., 2003) . Weak interactions are appropriate components of such regulatory switches, because they are reversible and avoid saturation with incorrect binding partners, such as other acetylated lysine residues. Our surprising finding that Rsc4 K25 is acetylated by Gcn5 both in vitro and in vivo reveals that yeast Gcn5 is both a HAT and a protein acetyltransferase. This is consistent with the roles of related enzymes such as PCAF and p300 in vertebrates (Gu and Roeder, 1997; Mujtaba et al., 2002) . Also surprising was our discovery that acetylated Rsc4 K25 bound to BD1. The biological relevance of the interaction is indicated by our growth competition and transcriptional profiling data. The magnitude of the selection coefficients obtained shows that prolonged stress conditions such as those examined would cause the loss of the mutant population (8.7% loss per generation). The likely mechanistic basis for the biological loss of fitness is our finding that this interaction inhibits binding of H3K14ac peptides to BD2. Another direction that merits future study is that BD1 and/or BD2 likely has additional binding partners; these bromodomains are essential for viability, whereas their currently identified ligands are not. To find them, we have tried many other histone tail peptide substrates in our in vitro binding assays, including H3 K9ac, H3 K23ac, H3 K9ac K18ac, and H3 K18ac K27ac in addition to the series tested previously (Kasten et al., 2004) . However, none of these provided acetyl-enhanced binding. In principle, the binding of Rsc4 TBDs to alternative ligands might be regulated by the mechanisms revealed here. For example, the binding of Rsc4 K25ac to BD1 might enhance the binding of another ligand to BD2. Alternatively, BD1 may bind an alternative ligand on a histone tail when K25 is not acetylated, leaving the BD1 pocket available and perhaps enabling cooperativity with H3K14ac bound in BD2. Gcn5 acetylates ligands for both BD1 and BD2, and these ligands compete for binding to Rsc4. This raises the possibility that Gcn5 activity serves as a switch; Gcn5 acetylation of H3K14 would favor RSC-nucleosome binding, and this interaction would be countered by acetylation of Rsc4 K25. One attractive possibility is that this mechanism regulates the residence time of RSC to sites of remodeling ( Figure 5C ). In this model, activators recruit Gcn5 to promoter regions where it acetylates H3K14. This recruits RSC to promote nucleosome sliding and enhance promoter accessibility and also places Rsc4 in the vicinity of Gcn5, which then acetylates K25 and triggers release of RSC from the now-remodeled nucleosome. Finally, autoregulatory mechanisms, in which a binding protein or enzyme adopts a repressed conformation in response to intramolecular binding of a posttranslationally attached group, have been extensively characterized for kinases (reviewed in Kuriyan and Cowburn, 1997) and recently described for ubiquitylation (Hoeller et al., 2006) . Our demonstration that RSC function is optimized by an analogous approach raises the possibility that mechanisms of this type might be widespread for acetylation and other modifications associated with chromatin dynamics.
EXPERIMENTAL PROCEDURES
See the Supplemental Data for details of media, strain lists, plasmid lists, protein expression and purification, in vitro acetylation, and crystallographic methods.
Histone Tail Binding Assay
Biotinylated histone tail peptides were bound to streptavidin beads (Invitrogen) as previously described (Kasten et al., 2004) and resuspended in a 50% slurry. Binding assays were conducted by rotating 15 ml of the peptide/bead slurry (20 nmol peptide/100 ml bed volume beads) with 500 ng purified Rsc4 protein in peptide binding buffer (PBB) (20 mM Tris [pH 7.5], 150 mM NaCl, 5% glycerol, 0.05% Tween-20, 1 mM EDTA, 1 mM b-mercaptoethanol, protease inhibitors) at 4 C for 3 hr. Typically, the beads were washed twice with PBB and twice with PBB containing 250 mM NaCl or the alternative NaCl concentrations indicated, followed by elution with 4 3 SDS sample buffer.
RSC Purification, Extract Preparation, Immunoprecipitation, and Antibodies RSC was purified as previously described . Wholecell extracts were prepared as previously described (Cairns et al., 1999) . Partially purified RSC was analyzed for Rsc4 acetylation in the gcn5D and rsc4 K25A mutant and was derived from whole-cell extracts lysed in 3 3 lysis buffer (60 mM HEPES [pH 7.6], 30% glycerol, 750 mM NaCl, 0.3% Tween-20, 30 mM EDTA, 1.5 mM DTT, protease inhibitors), which were then bound to IgG beads, washed three times with IPP150 (20 mM HEPES [pH 7.6], 10% glycerol, 150 mM NaCl, 0.1% Tween-20, 10 mM EDTA, 0.5 mM DTT, protease inhibitors), and eluted by boiling in 4 3 SDS sample buffer prior to western blot analysis. The anti-Rsc4 antibody was made to the full-length protein and was previously described (Kasten et al., 2004) . The anti-acetyl lysine antibody was from Cell Signaling.
Affinity Purification of Rsc4(1-340) from Yeast Rsc4(1-340) preceded by 10 3 HIS and 2 3 NLS sequences expressed in yeast was nickel affinity purified prior to examining acetylation. Whole-cell extracts were prepared as previously described (Saha et al., 2005) except in modified breaking buffer (12% glycerol, 50 mM Tris [pH 7.5], 0.1% Triton X-100, 500 mM NaCl, 1.5 mM b-mercaptoethanol, protease inhibitors). Extracts (3 mg) were incubated with 100 ml bed volume of Ni-NTA agarose (QIAGEN) for 3 hr at 4 C, poured into a small column, washed three times (1.2 ml) with wash buffer (50 mM NaPhosphate [pH 8.0], 150 mM NaCl, 10% glycerol) containing increasing amounts of imidazole (from 10 mM to 40 mM). Bound protein was eluted with wash buffer containing 300 mM imidazole and protease inhibitors prior to western blot analysis.
rsc4 K25A Fitness Determination Fitness determinations compared isogenic strains, differing only at rsc4 K25A mutation, which were prepared by standard yeast gene transplacement methods. Comparisons used a method based on (Thatcher et al., 1998) . Competition cocultures were established by inoculating 2 ml of YPD (rich media) or SD supplemented as needed for auxotrophies (minimal media) with 32 ml each from overnight cultures of YBC2898 and YBC2899 grown in YPD or SD. Equal numbers of cells (by OD reading) from each strain were inoculated, and cultures were incubated at 30 C or 37 C and were back diluted into fresh media daily. Each day, 1 ml of the competition coculture was collected and used to prepare genomic DNA using the YeaStar Genomic DNA kit (Zymo Research). Quantitative PCR (qPCR) was utilized to determine RSC4 genotype frequencies. Primers were designed so that the 3 0 ends recognize either the K25 or the K25A codon allowing these primers to differentiate between the two RSC4 alleles. Genomic DNA harvested periodically from the competition cocultures was used in separate qPCR procedures essentially as previously described (Roberts et al., 2003) to determine the quantity of each allele individually. Primer for RSC4 K25 detection was the following: (BC3550) GCCTAAATACTTGCCGGGAAAA. Primer for rsc4 K25A detection was the following: (BC3551) CTAAATACTTGCCGGGAGCC. RSC4 reverse primer used for detection of either allele was the following: (BC3539) TGTATTTGTCGATAAGAACATCCAAAGTG. The average of three PCR replicates was taken for each genomic DNA analyzed. The change in allele ratio with time is given by the equation ln(R t ) = ln(R 0 ) À st (where R 0 is the initial genotype ratio, R t is the ratio after t generations, and s is the selection coefficient) (Thatcher et al., 1998) . The selection coefficient for the rsc4 K25A mutant relative to WT in each growth condition was calculated by fitting the above equation to the qPCR frequency data. Table S3 . Yeast Rsc4 constructs were obtained from genomic DNA by PCR.
Supplemental Data
The H3-Rsc4(1-321) chimera was generated by PCR utilizing primers containing sequence for histone H3 (residues 6-18) followed by a thrombin protease recognition site with short linkers separating the thrombin site from both the histone and Rsc4 sequence.
Details of other plasmid constructions are available upon request. All plasmid constructs generated through PCR were sequence verified. Plasmids bearing site-directed mutations in RSC4 or histone H3 were prepared using the QuikChange method (Stratagene), subcloned, and fully sequenced. The pET151/D-TOPO vector used to express the recombinant Rsc4 proteins is from Invitrogen and results in fusion proteins that bear a 6xHis tag followed by the V5 epitope and a TEV recognition site at the amino terminus of the protein. Plasmids are listed in Table S4 .
Protein expression and purification
Wild type and mutant recombinant Rsc4(46-334) used in the binding assays in Figure 2B were expressed fused to N-terminal Flag and C-terminal 10xHis tags, and purified using standard methods. The purified proteins were analyzed or further purified by size exclusion chromatography on a Superdex 200 column (GE Healthcare).
All other Rsc4 constructs were expressed in E.coli Codon+ (RIL) cells (Stratagene) as
His-tagged fusions using a pET151/D-TOPO cloning/expression plasmid (Invitrogen).
Cells were grown in ZY autoinduction media (Studier, 2005) at room temperature for 24-30 hours, harvested by centrifugation, and lysed by sonication in 25 mM HEPES (pH 7.5), 500 mM NaCl, 5% glycerol, 10 mM imidazole, 0.5 mM β-mercaptoethanol. Rsc4
proteins were purified by nickel affinity chromatography (Qiagen), followed by an overnight digestion at room temperature with TEV protease in a dialysis bag against a buffer containing 20 mM HEPES (pH 8.0), 500 mM NaCl, 5% glycerol, and 0.5 mM β-mercaptoethanol. A second round of nickel affinity chromatography was used to remove any uncleaved protein and the His-tagged TEV protease. Gel filtration and buffer transfer was performed on a Superdex-200 column (GE Healthcare) in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2% glycerol, and 0.5 mM DTT, with peak fractions eluting as an apparent monomer. Protein was concentrated to 15 mg/ml and stored at 4ºC, where it was stable for many months. Selenomethionine-substituted Rsc4(36-340) was expressed (Van Duyne et al., 1993) and purified using the same protocol as native protein, with the addition of 5mM β-mercaptoethanol in the lysis and TEV cleavage buffers.
Gcn5 was expressed using a pET11a bacterial expression vector as a 7x N-terminal Histagged fusion. Gcn5 was expressed in E.coli using IPTG induction, lysed in 25mM HEPES (pH 7.5), 500 mM NaCl, 5% glycerol, and 1 mM β-mercaptoethanol, and purified via nickel chelating and gel filtration chromatography. Peak fractions were collected and dialyzed into 20 mM HEPES (pH 7.5), 200mM NaCl, and 50% glycerol, and stored at -80°C.
In vitro acetylation reactions
Purified Rsc4(1-340) or H3-Rsc4(1-321) proteins were concentrated to 15 mg/ml and acetylated in 20mM Tris (pH 7.5), 150 mM NaCl, 5% glycerol, 0.5 mM DTT, and 5 mM acetyl-CoA, and 1.0 mg/ml Gcn5. The reaction was carried out at 30°C for 60-90 minutes. Following acetylation, nickel affinity chromatography was used to remove the Gcn5 followed by gel filtration using a .5], 100 mM NaCl, 2% glycerol, and 0.5 mM DTT) to remove the excess acetyl-CoA.
Notably, the non-acetylated Rsc4 protein control was subjected to all the same procedures and components, with omission of Ac-CoA from the reaction, and acetylation specificity was confirmed by mass spectrometric analysis.
The efficiency of histone acetylation was monitored by cleaving a small amount with thrombin to release the histone portion of the chimera, followed by electrophoresis on a 15% acid-urea gel (Hirose, 1988) . Acetylation at Rsc4-K25 was identified by mass spectrometry of proteolytic digested protein using nanoelectrospray with a LTQ-FT mass spectrometer (ThermoElectron). Samples were introduced on a 75 μm ID x 10 cm column (C18) at 400 nl/min with an acetonitrile gradient (in 0.1% formic acid). Primary data were acquired in the FT part of the instrument (with less than 2 ppm mass error) and MS/MS/ data were acquired in LTQ (linear-ion-trap) part of the instrument. Database searches were performed with Mascot. Subsequent analysis of non-proteolyzed fragments by electrospray ionization mass spectrometry was performed using a Quattro-II (Micromass). After C18 ziptip desalting, the sample was introduced by infusion at 3 μl/min. Data were processed into molecular mass spectra with MaxEnt software (Micromass). These data revealed that the product was overwhelmingly a doubly acetylated protein for the Rsc4:Histone chimera and a singly acetylated protein when the Rsc4(1-340) protein is used.
Crystallization
Prior to crystallization, purified proteins were concentrated to 15 mg/ml in the gel filtration buffer using a Vivaspin concentrator (Millipore). 
Structure Determinations
SAD data were collected to 3.0 Å resolution from a crystal of selenomethioninesubstituted Rsc4(36-340) and processed with HKL2000. SOLVE (Terwilliger and Berendzen, 1999 ) located six Se sites and generated a readily interpretable map. Initial model building was performed by RESOLVE, followed by manual model building in Xfit (McRee, 1999) . High resolution data on Rsc4(36-340) was collected in house using an RAXIS-IV detector (Rigaku) and processed with DENZO and SCALEPACK (Otwinowski and Minor, 1997) . All other data were collected at NSLS beamline X26-C and processed with HKL2000 (Otwinowski and Minor, 1997) . Structures of acetylated Rsc4 constructs were determined by molecular replacement using PHASER (McCoy et al., 2005) and the Rsc4(36-321) fragment as a search model. Model building was performed using COOT (Emsley and Cowtan, 2004 ), and refinement with TLS parameters was performed using REFMAC as implemented in CCP4i (1994) . TLS parameters were generated using the TLSMD server (Painter and Merritt, 2006) .
Microarray Analysis
RNA was prepared from strains YBC2898 and YBC2899 grown at 33°C in SD supplemented with lysine, methionine, histidine, leucine, and uracil and labeled using the Agilent Low RNA Input Linear Amplification kit. Labeled samples were applied to a four-pack yeast expression slide (Agilent, catalog # G2519F AMADID 015072).
Hybridization, washes, data extraction and normalization were performed according to manufacturer's protocol. Data from four independent experiments were averaged and the resulting (mutant/wt) mean ratios are reported. Pearson correlation coefficients (r values)
were determined by plotting genome-wide expression data for one experimental replicate versus another as a moving average (window = 5% of data set, step-size = 1) for all possible pairwise comparisons. For each pairwise comparison r ≥ 0.90.
RSC immunoprecipitation and antibodies
Flag immunoprecipitations for RSC assembly assays were performed by incubating 1 mg of whole-cell extract (Cairns et al., 1999) with 20 μl bed volume of anti-Flag agarose (Sigma) in Flag Buffer 300 (50 mM NaPhosphate [pH 7.5], 300 mM NaCl, 20 mM EDTA, 10% glycerol, 1 mM β-mercaptoethanol, protease inhibitors) at 4°C for 3 h. The immunocomplexes were washed four times with Flag Buffer 300, eluted by boiling with 4 x SDS sample buffer, prior to Western blot analysis. The anti-Sth1 antibody was previously described . The anti-Flag antibody is from Sigma. Figure S1 . Structural alignment of TAF II 1 double bromodomain with the Rsc4 TBD.
Upper) Rsc4 Tandem bromodomain colored as in Figure 1B , with BD1 (cyan), BD2 (blue), Wing (orange) The TAF II 1 double bromodomain is shown in grey . Residues important for acetyl-lysine recognition indicated in yellow for both structures. Structural alignment of bromodomain 1 performed using the DALI server (Holm and Sander, 1998) . Tandem bromodomain colored as in Figure 1B , with BD1 (cyan), BD2 (blue), Wing (orange), and residues important for acetyl-lysine recognition indicated in yellow. Residues that form the interface between BD1 (defined as residues 36-162), and BD2 (residues 163-320) are shown in red. Sequence alignment of a selection of structurally characterized bromodomains (aligned with CLUSTALW). Highly conserved residues (green), invariant residues (red). Residues involved in acetyl-lysine recognition (yellow dots). PDB codes for sequences are TAF II 1 (1EQF), PCAF (1JM4), CBP (1JSP), Brd2 (1X0J), Peregrin (2D9E).
Figure S4. K25 affects Rsc4 TBD function in vivo.
A) A Rsc4 peptide acetylated at K25 binds weakly to the TBD in trans. The format to assess binding is identical to the methods used in Figure 2 . Peptides correspond to aa 18-34 of the Rsc4 sequence, either unmodified or acetylated at the Rsc4 Table S1 . Genes up-regulated ≥2-fold in rsc4K25A mutant -only genes where 3 of 4 replicates were up-regulated ≥1.5-fold 
